Company Name : Arab Pharmaceuticals ISIN Code : EGS38321C013 Reuters Code : ADCI.CA Content : The listing committee held on 03/03/2026 decided to accept the Re-offer request and reverse the decision of the listing committee at its meeting held on 17/02/2026 .